Supporting the development of independent scientists in HIV-related cancer research
Developmental Core
This study is all about helping new scientists in East Africa who are working on HIV-related cancers by giving them better training and support, so they can grow in their careers and compete for important research funding.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10866361 on NIH RePORTER |
What this research studies
This research focuses on enhancing the training and support for junior scientists in East Africa, particularly in the field of HIV-associated malignancies. It aims to create a robust academic environment that fosters career development through mentorship and protected research time. By addressing the unique challenges faced by emerging researchers in this region, the project seeks to prepare them for competitive funding opportunities like the K43 Emerging Global Leader Award. The initiative will also strengthen collaborations between U.S. and East African institutions to improve research outcomes.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include junior scientists and researchers in East Africa focusing on HIV-associated malignancies.
Not a fit: Patients who are not involved in academic or research training related to HIV-associated cancers may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new generation of independent scientists capable of advancing the understanding and treatment of HIV-related cancers.
How similar studies have performed: Similar initiatives have shown success in enhancing research capacity and training in other regions, indicating a promising potential for this approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Kambugu, Andrew Ddungu — University of California, San Francisco
- Study coordinator: Kambugu, Andrew Ddungu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.